Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 69, Issue 5, 2000, Pages 1402-1407

  Liu, Yinglong ^a   Wang, Qiang ^a   Zhu, Xiaodong ^a   Liu, Dongqing ^a   Pan, Shiwei ^a   Ruan, Yingmao ^a   Li, Yongli ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANISODAMINE; ANTIINFLAMMATORY AGENT; APROTININ; ARGININE; CARDIOPLEGIC AGENT; GLUCOSE; INSULIN; MALONALDEHYDE; PHOSPHATE; POTASSIUM; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; HISTOPATHOLOGY; INFLAMMATION; LEUKOCYTE COUNT; LUNG BIOPSY; LUNG EDEMA; LUNG FUNCTION; LUNG INJURY; LUNG PERFUSION; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STERNOTOMY; VENOUS OXYGEN TENSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOPULMONARY BYPASS; COLD; DOGS; LEUKOCYTE COUNT; LUNG; MALONDIALDEHYDE; PERFUSION; PULMONARY ARTERY; RANDOM ALLOCATION;

EID: 0033946380     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01161-9     Document Type: Article

References (30)

1. Blackstone E.H., Kirklin J.W., Stewart R.W., Chenoweth D.E. The damaging effects of cardiopulmonary bypass. Wu K.K., Rossi E.C. Prostaglandins in clinical medicine cardiovascular and thrombotic disorders . 1982;355-369 Year Book Medical, Chicago.
2. Cave A.C., Manche A., Derias N.W., Hearse D.J. Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit. J Thorac Cardiovasc Surg. 106:1993;959-967.
3. Tennenberg S.D., Clardy C.W., Bailey W.W., Solomkin J.S. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg. 50:1990;597-601.
4. Bando K., Pillai R., Cameron D.E., et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 99:1990;873-877.
5. Gadaleta D., Fahey A.L., Verma M., et al. Neutrophil leukotriene generation increase after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 108:1994;642-647.
6. Watchtfogel Y.T., Kucich U., Greenplate J., et al. Human neutrophil degranulation during extracorporeal circulation. Blood. 69:1987;324-330.
7. Riegel W., Spillner G., Schlosser V., Horl W.H. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 95:1988;1014-1019.
8. Hachida M., Morton D.L. A new solution (UCLA formula) for lung preservation. J Thorac Cardiovasc Surg. 97:1989;513-520.
9. Hachida M., Hoon S.B., Morton D.L. A comparison of solutions for lung preservation using pulmonary alveolar epithelial cells viability. Ann Thorac Surg. 45:1988;643-646.
10. Crane R., Torres M., Hagstrom J.W.C., Koerner S.K., Veith F.J. Twenty-four-hour preservation and transplantation of the lung without functional impairment. Surg Forum. 26:1975;111-113.
11. Ma X., Weyrich A.S., Lefer D.J., Lefer A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 72:1993;403-412.
12. Seccombe J.F., Pearson P.J., Schaff H.V. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J Thorac Cardiovasc Surg. 107:1994;505-509.
13. Hill G.E., Alonso A., Spurzem J.R., Stammers A.H., Robbins R.A. Aprotinin and methylprednisolone equally blunt CPB-induced inflammation in humans. J Thorac Cardiovasc Surg. 110:1995;1658-1662.
14. Friedman M., Sellke F.W., Wang S.Y., Weintraub R.M., Johnson R.G. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 90:(suppl 2):1994;262-268.
15. Stahl R.F., Fisher C.A., Kucich U., et al. Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity. J Thorac Cardiovasc Surg. 101:1991;230-239.
16. Hachida M., Morton D.L. The protection of ischemic lung with verapamil and hydralazine. J Thorac Cardiovasc Surg. 95:1988;178-183.
17. Colman R.W. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg. 49:1990;32-34.
18. Hammerschmidt D.E., Stroncek D.F., Bowers T.K., et al. Complement activation and neutropenia occuring cardiopulmonary bypass. J Thorac Cardiovasc Surg. 81:1981;370-377.
19. Kongsgaard V.E., Smith-Erichsen N., Geiran O., Amundsen E., Mollnes T.E., Garred P. Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery. Acta Anaesthesiol Scand. 33:1989;343-347.
20. Kirklin J.K., Westaby S., Blacktone E.H., Kirklin J.W., Chenoweth D.E., Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 86:1983;845-857.
21. Dreyer W.J., Michael L.H., Millman E.E., Berens K.L. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass. Cardiovascular Res. 29:1995;775-781.
22. Liu B., Belboul A., Al-Khaja N., et al. Effect of high-dose aprotinin on blood cell filterability in association with CPB. Coronary Artery Dis. 3:1992;129-132.
23. Xiu R.J., Hammerschmidt D.E., Coppo P.A., Jacob H.S. Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation a possible mechanism for its efficacy in bacteremic shock . JAMA. 247:1982;1458-1460.
24. Allen S., Anastasiou N., Royston D., Paniagua R., Yacoub M. Effect of aprotinin on vascular reactivity of coronary artery bypass grafts. J Thorac Cardiovasc Surg. 113:1997;319-326.
25. Royston D. Aprotinin versus lysine analogues: the debate continues. Ann Thorac Surg 1998;65:S9-19.
26. Wang J.H., Redmond H.P., Watson R.W., et al. Mechanisms involved in the induction of human endothelial cell necrosis. Cell Immunol. 168:1996;91-99.
27. Hiramatsu T., Forbess J.W., Miura T., Mayer J.E. Effects of L-arginine and l-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. J Thorac Cardiovasc Surg. 109:1995;81-87.
28. Rubanyi G.M., Ho E.H., Cantor E.H., Lumma W.C., Parker-Botelho L.H. Cytoprotective function of nitric oxide inactivation of superoxide radicals produced by human leukocytes . Biochem Biophys Res Commun. 181:1991;1392-1397.
29. Provost P., Lam J.Y.T., Lacoste L., Merhi Y., Waters D. Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscler Thromb. 14:1994;331-335.
30. Carrier M., Khalil A., Tourigny A., Solymoss B.C., Pelletier L.C. Effect of L-arginine on metabolic recovery of the ischemic myocardium. Ann Thorac Surg. 61:1996;1651-1657.